Confidential
Dear Madam Zhorzholadze,
Dear Madam Adamia,
This is just to clarify some points of the conditions and terms within the commercial offer shared while the meeting, that might be useful for your calculations :
•
The product Varenicline (Champix®) to be supplied in the frame of the Agreement should have not less than 20 months of the rest shelf life at the date of delivery: total Champix shelf life is
36 months. 20 months of shelf life at delivery to Georgia date is the minimum rest shelf life guaranteed;
•
Shipment terms: CIP Tbilisi airport (Incoterm 2010), split shipments are possible: Pfizer is supplying products by air, split shipments are allowed: it means that the proposed annual volume out of total offer
volume can be supplied by split shipments, several times per year (2-3 times). Once the payable volume is purchased, Pfizer will be able to send the FOC shipment (either by separate shipment or together with the last payable shipment). 2nd treatment
course (up to 30% of the patients treated) will be provided by a separate written confirmation -request from the Ministry of Healthcare , confirming the number of patients who needs the 2nd treatment course.
•
Agreement currency: US Dollars
•
Agreement duration: 3.5 years (2019-2022): as agreed while the meeting , once the in-principal feedback is received from the Ministry and Parliament HC committee and if it is positive decision, we will request
Pfizer HQs on the project delay required for budget allocation form Georgia side. However the consumption was calculated to cover 3.5 year demand.
•
Agreement payment terms: 100% prepayment :
prepayment is to be proceeded for each of the split shipments separately.
•
Agreement delivery terms: 45 days after prepayment arrives to the Pfizer’s bank account: once the prepayment amount is received to Pfizer bank account , the split shipment is to be initiated.
Pfizer is considering partnership solutions with the Georgian clinics for them to propose the Ministry
free of charge individual behavioral counselling support (1+5) for the socially vulnerable smokers willing to quit and included into the project of nicotine dependence treatment
In addition, Pfizer is ready to educate HCPs providing counselling as well as deliver specially developed educational materials to Patients;
Hope it will be helpful,
Should you need any further information
Yuliya Sultanova
Commercial manager, Pfizer Innovative Health CauCAR
Mail to: CauCARCom@pfizer.com
Mob. +7 778 747 47 42
Dear Madam Zhorzholadze,
Dear Madam Adamia,
Thank you for your time spent while the recent meeting with Pfizer.
As it was agreed , let us share with you the demonstrated data background, to support your further assessment of Pfizer offer.
Should you need any additional information, like FDA, EU international guidelines, experience of NHS (UK) for organization of SC services , let us know please, we will try to arrange it for you.
Kind regards
Yuliya Sultanova
Commercial manager, Pfizer Innovative Health CauCAR
Mail to: CauCARCom@pfizer.com
Mob. +7 778 747 47 42